Health is Our Passion and Priority
Astellas Pharma US is focused on providing safe and effective products that improve people's lives. We are committed to making a difference for our patients today and providing them with a brighter future tomorrow.
This commitment extends to providing resources for our patients and their physicians and caregivers that help them throughout the life cycle of their condition and beyond.
Below is a list of Astellas' products marketed in the U.S. This information is intended for U.S. residents only.
View Astellas products for the global market on our global website.
Cardiology
Lexiscan® (regadenoson) injection
Immunology
ASTAGRAF XL® (tacrolimus extended-release capsules)
Prograf® (tacrolimus) capsules, granules and injection
Infectious Disease
AmBisome® (amphotericin B) liposome for injection
CRESEMBA® (isavuconazonium sulfate)
MYCAMINE® (micafungin for injection) for intravenous use
Oncology
XTANDI® (enzalutamide) capsules
XOSPATA® (gilteritinib) tablets
PADCEV® (enfortumab vedotin-ejfv)
Urology
Myrbetriq® (mirabegron extended-release tablets)
Myrbetriq® Granules (mirabegron for extended-release oral suspension)
VESIcare® (solifenacin succinate) tablets
VESIcare LS® (solifenacin succinate) oral suspension
This information is intended for U.S. residents only.
All trademarks are Astellas’ except:
AmBisome is a registered trademark of Gilead Sciences, Inc.
1 Astellas Way, Northbrook, IL 60062, an affiliate of Astellas Pharma US, Inc.
